ニュース

Advanced Micro Devices (AMD) has gained more than 100% year to date, according to Yahoo Finance at the time of writing, Friday morning, May 15. Meanwhile, the SPDR S&P 500 index (SPY) is up slightly below 10% in the same period. AMD has outpaced the S&P 500 by a huge margin. That is ...

Wells Fargo just delivered one of the most dramatic large-cap semiconductor revisions of the year, raising its price target on Broadcom (NASDAQ:AVGO) to $545 from $430 while maintaining an Overweight rating. The driver is a new “pluggable gigawatt-driven” framework that ties AI silicon demand to physical data center power capacity, implying AI semiconductor revenue is ... Wells Fargo Just Hiked Broadcom Price Target to $545: AI Semi Revenue Running 30-40% Higher Than Expected

Broadcom stock picked up a fresh price target raise from Citi on Tuesday, with analyst Atif Malik lifting his target to $500 from $475 while maintaining a Buy rating. Broadcom (NASDAQ:AVGO) was framed in Citi’s note as an earnings preview call, with the firm pointing to stronger AI demand driving the April quarter modestly above ... Citi Raises Broadcom Price Target to $500: AI Demand Sets Up Another Big April Quarter

RBC sees a “two-speed” economy boosting tech, which could take the benchmark 10% higher over the next year.

Shares of Advanced Micro Devices (NASDAQ:AMD) are up by about 14% in early Wednesday trading, changing hands near $406 after a triple-catalyst night that combined a Q1 2026 beat, a sharply higher Q2 2026 outlook, and a Goldman Sachs upgrade. Premarket gains ran closer to 20% before the open trimmed the move. The rally extends ... AMD Soars 14%: Q1 Crusher, Q2 Guide Lift, Goldman $450 Price Target Ignite AI Frenzy

Investing.com -- Here are the biggest analyst moves in the area of artificial intelligence (AI) for this week.

Meta Platforms, Inc. (NASDAQ:META) is one of the 10 Best American Tech Stocks to Buy. On April 30, Stifel reduced its price target on Meta Platforms, Inc. (NASDAQ:META) from $805 to $780 and kept its Buy rating on the stock. The research firm pointed out that Meta Platforms, Inc.’s (NASDAQ:META) GAAP earnings per share surpassed […]

Mark Cuban isn't grading for style points—he's grading for impact. The billionaire co-founder of Cost Plus Drugs revisited TrumpRx and made clear what matters most: if it pressures the right players, it's working. From "B" To ‘A-' — Why The...